iRhythm Holdings, Inc. Common Stock (IRTC) is a publicly traded Healthcare sector company. As of May 21, 2026, IRTC trades at $117.02 with a market cap of $3.65B and a P/E ratio of -83.62. IRTC moved +2.80% today. Year to date, IRTC is -36.55%; over the trailing twelve months it is -17.14%. Its 52-week range spans $55.92 to $212.00. Analyst consensus is strong buy with an average price target of $184.00. Rallies surfaces IRTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
iRhythm Q1 Revenue Jumps 25.7% to $199.4M; Full-Year Guidance Upgraded: iRhythm reported Q1 2026 revenue of $199.4 million, up 25.7% year-over-year, with gross margin rising 210 basis points to 70.9% and net loss narrowing to $13.9 million. It raised full-year revenue guidance to $875–885 million and adjusted EBITDA margin to 12–13% on stronger volume-led growth and operational leverage.
| Metric | Value |
|---|---|
| Price | $117.02 |
| Market Cap | $3.65B |
| P/E Ratio | -83.62 |
| EPS | $-1.39 |
| Dividend Yield | 0.00% |
| 52-Week High | $212.00 |
| 52-Week Low | $55.92 |
| Volume | 274.56K |
| Avg Volume | 0 |
| Revenue (TTM) | $747.14M |
| Net Income | $-44.55M |
| Gross Margin | 70.57% |
13 analysts cover IRTC: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $184.00.